Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care

Launched by UNIVERSITY HOSPITAL MUENSTER · Oct 16, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how to improve the process of moving patients who are receiving palliative care from the hospital to their homes. Palliative care is specialized care that focuses on providing relief from the symptoms and stress of serious illnesses like cancer, heart failure, and chronic obstructive pulmonary disease (COPD). The trial will involve a trained pharmacist who will help manage the medications of these patients during their transition to outpatient care, ensuring they receive the right medications and support as they leave the hospital.

To participate in this trial, patients should be between the ages of 65 and 74 and have advanced illnesses, such as severe cancer or COPD, with a life expectancy of about 12 months. They also need to be able to understand and communicate in German to give informed consent. Participants can expect to receive careful support from healthcare professionals as they transition to receiving care at home. This study aims to gather valuable information that can help improve the way medications are managed for palliative care patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• All individual indications for general and specialised palliative care as part of routine clinical practice (e.g.):
• • advanced, malignant tumour disease
• • advanced, chronic obstructive pulmonary disease
• • Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form
• Exclusion Criteria:
• • Impossibility of understanding the information and declaration of consent.